发明名称 Inhibition of tumor growth
摘要 The present invention provides a cytotoxic 7 to 25 mer peptide with three or more cationic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them and their use as medicaments, particularly as antibacterions or antitumoral agents. In a preferred aspect, the invention provides the use of said peptides in a method of inducing adaptive immunity against tumor growth or establishment in a subject, as well as the use of other lytic agents in a method of inducing adaptive immunity in a subject.
申请公布号 US9109048(B2) 申请公布日期 2015.08.18
申请号 US201213585232 申请日期 2012.08.14
申请人 LYTIX BIOPHARMA AS 发明人 Eliassen Liv Tone;Berge Gerd;Sveinbjørnsson Baldur;Svendsen John Sigurd;Rekdal Øystein
分类号 C07K14/79;A61K39/00 主分类号 C07K14/79
代理机构 Fox Rothschild LLP 代理人 Fox Rothschild LLP
主权项 1. A method of inducing adaptive immunity against tumour growth or establishment in a subject having a tumour, comprising administration of an effective amount of a lytic peptide or peptidomimetic to said subject, wherein said peptide or peptidomimetic is from 3 to 30 amino acids or equivalent in length, and comprises two or more cationic residues and one or more bulky and lipophilic residues, wherein said bulky and lipophilic residues comprise a side chain containing 7 or more non-hydrogen atoms, said peptide or peptidomimetic may be cyclic or in the form of an ester, amide or salt, and whereby adaptive immunity against tumour growth or establishment is induced.
地址 TromsØ NO